Abstract
Accurate measurement of IgA monoclonal proteins presents a significant challenge to laboratory staff. IgA heavy/light chain (Hevylite, HLC) analysis is an alternative methodology for monoclonal protein assessment, giving an independent measure of IgAκ and IgAλ concentrations. Clonality is assessed by calculating the ratio of involved immunoglobulin to background uninvolved immunoglobulin concentrations (e.g. IgAκ/IgAλ in an IgAκ patient). Here we discuss the challenges faced by the laboratory in IgA monoclonal protein assessment, and compare the performance of Hevylite assays with electrophoresis and total IgA results. We present data which validates the use of Hevylite for response assessment: in most cases, Hevylite provides comparable response assignment to that provided by serum protein electrophoresis (SPE) and total IgA; in other cases Hevylite provides additional information, such as detection of residual disease or relapse.
References
1. Woof JM, Russell MW. Structure and function relationships in IgA. Mucosal Immunol 2011;4:590–7.10.1038/mi.2011.39Search in Google Scholar PubMed
2. Bradwell AR, Harding SJ, Fourrier NJ, Wallis GL, Drayson MT, Carr-Smith HD, et al. Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa/lambda ratios. Clin Chem 2009;55:1646–55.10.1373/clinchem.2009.123828Search in Google Scholar PubMed
3. Murphy K. Janeway’s Immunobiology, 8th ed. New York, USA: Garland Science, 2011:157–200.Search in Google Scholar
4. Boyle EM, Fouquet G, Guidez S, Bonnet S, Demarquette H, Dulery R, et al. IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma. Cancer 2014;120:3952–7.10.1002/cncr.28946Search in Google Scholar PubMed
5. Katzmann JA, Willrich MA, Kohlhagen MC, Kyle RA, Murray DL, Snyder MR, et al. Monitoring IgA multiple myeloma: immunoglobulin heavy/light chain assays. Clin Chem 2015;61:360–7.10.1373/clinchem.2014.231985Search in Google Scholar PubMed
6. Keren DF. Protein electrophoresis in clinical diagnosis. Chicago, USA: ASCP Press, 2012.10.1007/978-1-61779-821-4Search in Google Scholar
7. Roberts-Thomson PJ, Mason DY, MacLennan IC. Relationship between paraprotein polymerization and clinical features in IgA myeloma. Br J Haematol 1976;33:117–30.10.1111/j.1365-2141.1976.tb00978.xSearch in Google Scholar PubMed
8. Murray DL, Ryu E, Snyder MR, Katzmann JA. Quantitation of serum monoclonal proteins: relation of agarose gel electrophoresis M-spike and nephelometric concentration. Clin Chem 2009;55:C63a.10.1373/clinchem.2009.124461Search in Google Scholar PubMed
9. Katzmann JA, Snyder MR, Rajkumar SV, Kyle RA, Therneau TM, Benson JT, et al. Long-term biologic variation of serum protein electrophoresis M-spike, urine M-spike, and monoclonal serum free light chain quantification: implications for monitoring monoclonal gammopathies. Clin Chem 2011; 57:1687–92.10.1373/clinchem.2011.171314Search in Google Scholar PubMed PubMed Central
10. Batinic J, Peric Z, Segulja D, Last J, Prijic S, Dubravcic K, et al. Immunoglobulin heavy/light chain analysis enhances the detection of residual disease and monitoring of multiple myeloma patients. Croat Med J 2015;56:263–71.10.3325/cmj.2015.56.263Search in Google Scholar PubMed PubMed Central
11. Ludwig H, Milosavljevic D, Zojer N, Faint JM, Bradwell AR, Hubl W, et al. Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients. Leukemia 2013;27:213–9.10.1038/leu.2012.197Search in Google Scholar PubMed PubMed Central
12. Mirbahai L, Fourrier NJ, Harper J, Harris J, Bradwell AR, Harding SJ. Monoclonal IgA proteins migrating into the β region of serum protein electrophoresis gels can be easily identified and quantified using IgAκ and IgAλ measurements. Clin Chem 2011;57:C-64a.Search in Google Scholar
13. Donato LJ, Zeldenrust SR, Murray DL, Katzmann JA. A 71-year-old woman with multiple myeloma status after stem cell transplantation. Clin Chem 2011;57:1645–8.10.1373/clinchem.2011.163766Search in Google Scholar PubMed
14. Katzmann JA, Clark R, Kyle RA, Larson DR, Therneau TM, Melton LJ, III, et al. Suppression of uninvolved immunoglobulins defined by heavy/light-chain pair suppression is a risk factor for progression of MGUS. Leukemia 2013;27:208–12.10.1038/leu.2012.189Search in Google Scholar PubMed PubMed Central
15. Tate J, Caldwell G, Daly J, Gillis D, Jenkins M, Jovanovich S, et al. Recommendations for standardized reporting of protein electrophoresis in Australia and New Zealand. Ann Clin Biochem 2012;49:242–56.10.1258/acb.2011.011158Search in Google Scholar PubMed
16. Adie L, Berlanga O, Carr-Smith H, Harding S. Comparison of the performance of the newly developed IgA heavy chain/light chain immunoassays with serum protein electrophoresis and nephelometric total IgA measurements for monitoring IgA multiple myeloma patients. Clin Chem Lab Med 2014;52:0688a.10.1016/j.clml.2015.07.363Search in Google Scholar
17. Young P, Ludwig H, Zojer N, Milosavljevic D, Harding S. Use of heavy/light chain (HLC) and free light chain (FLC) ratios for monitoring oligosecretory multiple myeloma patients. Clin Lymphoma Myeloma Leuk 2013;13:P-236a.Search in Google Scholar
©2016 by De Gruyter
